[ Price : $8.95]
University of Chicago researchers explain how difficult it will be to improve government oversight over social media influencer pr...[ Price : $8.95]
FDA qualifies glutamate hydrogenase as a biomarker to enhance liver safety monitoring in clinical trials.[ Price : $8.95]
Gilead Sciences says its investigational single-tablet regimen combining bictegravir and lenacapavir met its primary endpoint in a...[ Price : $8.95]
FDA accepts for review an Outlook Therapeutics BLA resubmission for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic for...[ Price : $8.95]
The CDER Office of Generic Drugs publishes a MAPP to help assessors use the four-part harmony approach in OGD-related communicatio...[ Price : $8.95]
Alkermes announces that its investigational once-daily therapy alixorexton significantly improved wakefulness and reduced daytime ...[ Price : $8.95]
A MAHA Summit on 11/19 will hear from vice president JD Vance, HHS secretary Robert F. Kennedy, Jr., and FDA commissioner Marty Ma...[ Price : $8.95]
A biotechnology company specializing in adult-derived stem cells urges FDA to relax federal regulation of some regenerative therap...